Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 15 results:
[ Author(Asc)] Title Type Year
Filters: Author is Meier, C. R.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
C. R. Meier, Derby, L. E., Jick, S. S., Vasilakis, C., and Jick, H., Antibiotics and risk of subsequent first-time acute myocardial infarction, Jama, vol. 281, pp. 427-31, 1999.
C. R. Meier, Derby, L. E., Jick, S. S., and Jick, H., Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer, Arch Intern Med, vol. 160, pp. 349-53, 2000.
C. R. Meier, Napalkov, P. N., Wegmuller, Y., Jefferson, T., and Jick, H., Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom, Eur J Clin Microbiol Infect Dis, vol. 19, pp. 834-42, 2000.
C. R. Meier, Antibiotics in the prevention and treatment of coronary heart disease, J Infect Dis, vol. 181 Suppl 3, pp. S558-62, 2000.
C. R. Meier, Schlienger, R. G., Kraenzlin, M. E., Schlegel, B., and Jick, H., HMG-CoA reductase inhibitors and the risk of fractures, Jama, vol. 283, pp. 3205-10, 2000.
C. R. Meier, Schlienger, R. G., and Jick, H., Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction, Br J Clin Pharmacol, vol. 52, pp. 179-84, 2001.
C. R. Meier, Krahenbuhl, S., Schlienger, R. G., and Jick, H., Association between body mass index and liver disorders: an epidemiological study, J Hepatol, vol. 37, pp. 741-7, 2002.
C. R. Meier, Schmitz, S., and Jick, H., Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer, Pharmacotherapy, vol. 22, pp. 303-9, 2002.
C. R. Meier, Wilcock, K., and Jick, S. S., The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials, Drug Saf, vol. 27, pp. 203-13, 2004.
C. R. Meier and Jick, H., Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK, Thorax, vol. 52, pp. 612-7, 1997.
C. R. Meier and Jick, H., Omeprazole, H2 blockers, and polyarthralgia: case-control study, Bmj, vol. 315, p. 1283, 1997.
C. R. Meier and Jick, H., Omeprazole, other antiulcer drugs and newly diagnosed gout, Br J Clin Pharmacol, vol. 44, pp. 175-8, 1997.
C. R. Meier and Jick, H., Tamoxifen and risk of idiopathic venous thromboembolism, Br J Clin Pharmacol, vol. 45, pp. 608-12, 1998.
C. R. Meier, Jick, S. S., Derby, L. E., Vasilakis, C., and Jick, H., Acute respiratory-tract infections and risk of first-time acute myocardial infarction, Lancet, vol. 351, pp. 1467-71, 1998.
C. R. Meier, Sturkenboom, M. C., Cohen, A. S., and Jick, H., Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus, J Rheumatol, vol. 25, pp. 1515-9, 1998.
[Page last reviewed 4 October 2019]